Dalvinder Mandair

1.7k total citations
50 papers, 944 citations indexed

About

Dalvinder Mandair is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Dalvinder Mandair has authored 50 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 38 papers in Oncology and 19 papers in Neurology. Recurrent topics in Dalvinder Mandair's work include Neuroendocrine Tumor Research Advances (43 papers), Lung Cancer Research Studies (29 papers) and Neuroblastoma Research and Treatments (19 papers). Dalvinder Mandair is often cited by papers focused on Neuroendocrine Tumor Research Advances (43 papers), Lung Cancer Research Studies (29 papers) and Neuroblastoma Research and Treatments (19 papers). Dalvinder Mandair collaborates with scholars based in United Kingdom, Germany and Italy. Dalvinder Mandair's co-authors include Martyn Caplin, Marinos Pericleous, Tara Whyand, Roberta Rossi, Christos Toumpanakis, Faidon‐Marios Laskaratos, Elwyn Elias, Christina Thirlwell, Krista Rombouts and Shaunak Navalkissoor and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Dalvinder Mandair

47 papers receiving 921 citations

Peers

Dalvinder Mandair
Marinos Pericleous United Kingdom
Alexandros Papalampros Greece
Richard Ho United States
Joseph K. Lim United States
Gerald Denk Germany
Anne Davit–Spraul France
G. Mantion France
Francesca Carubbi Italy
S. Krähenbühl Switzerland
Marinos Pericleous United Kingdom
Dalvinder Mandair
Citations per year, relative to Dalvinder Mandair Dalvinder Mandair (= 1×) peers Marinos Pericleous

Countries citing papers authored by Dalvinder Mandair

Since Specialization
Citations

This map shows the geographic impact of Dalvinder Mandair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalvinder Mandair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalvinder Mandair more than expected).

Fields of papers citing papers by Dalvinder Mandair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalvinder Mandair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalvinder Mandair. The network helps show where Dalvinder Mandair may publish in the future.

Co-authorship network of co-authors of Dalvinder Mandair

This figure shows the co-authorship network connecting the top 25 collaborators of Dalvinder Mandair. A scholar is included among the top collaborators of Dalvinder Mandair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalvinder Mandair. Dalvinder Mandair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Armeni, Eleni, Juliana Barreiros Porto, Dalvinder Mandair, et al.. (2025). Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas. PubMed. 5(1). e240083–e240083.
2.
Mandair, Dalvinder, Alessandro Rimondi, Maria Rinzivillo, et al.. (2025). The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm. Digestive and Liver Disease. 58(1). 119–124. 1 indexed citations
3.
Glover, Thomas, Aimee R. Hayes, Dalvinder Mandair, et al.. (2024). Neuroendocrine tumours and pregnancy: Real‐world data from an European Neuroendocrine Tumour Centre of Excellence. Journal of Neuroendocrinology. 37(1). e13465–e13465.
4.
Kmiotek, Elizabeth, Aditya Borakati, Olagunju Ogunbiyi, et al.. (2023). Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review. Current Oncology. 30(10). 9192–9204.
5.
Ramage, John, Elizabeth Friend, Barbara King, et al.. (2022). Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module). Journal of Neuroendocrinology. 34(4). e13097–e13097. 4 indexed citations
6.
Gnanasegaran, Gopinath, Ann‐Marie Quigley, Dalvinder Mandair, et al.. (2022). Single centre retrospective review of outcome of 177 Lu‐DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors. Journal of Neuroendocrinology. 34(11). e13210–e13210. 5 indexed citations
7.
Gnanasegaran, Gopinath, et al.. (2022). Safety of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease. Journal of Nuclear Medicine. 63(10). 1503–1508. 9 indexed citations
8.
Navalkissoor, Shaunak, Ann‐Marie Quigley, Gopinath Gnanasegaran, et al.. (2021). 177Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3582–3594. 6 indexed citations
9.
10.
Liu, Man, Eleni Armeni, Shaunak Navalkissoor, et al.. (2020). Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications. Neuroendocrinology. 111(10). 907–924. 12 indexed citations
11.
Diamantopoulos, Leonidas Nikolaos, Faidon‐Marios Laskaratos, Markos Kalligeros, et al.. (2020). Antiproliferative Effect of Above-Label Doses of Somatostatin Analogs for the Management of Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 111(7). 650–659. 18 indexed citations
12.
Armeni, Eleni, Nicholas Cox, Dalvinder Mandair, et al.. (2019). Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes. Endocrine. 67(2). 485–493. 21 indexed citations
13.
Laskaratos, Faidon‐Marios, Dalvinder Mandair, Andrew Hall, et al.. (2019). Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms. Endocrine. 67(3). 718–726. 13 indexed citations
14.
Laskaratos, Faidon‐Marios, Eleni Armeni, Aimee R. Hayes, et al.. (2019). Predictors of antiproliferative effect of lanreotide autogel in advanced gastroenteropancreatic neuroendocrine neoplasms. Endocrine. 67(1). 233–242. 5 indexed citations
15.
Rizzo, Francesca, Teresa Marafioti, Mohid S. Khan, et al.. (2019). Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours. British Journal of Cancer. 120(3). 294–300. 29 indexed citations
16.
Diamantopoulos, Leonidas Nikolaos, Martin Walker, Henry Walton, et al.. (2018). Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia. Neuroendocrinology. 106(4). 366–380. 23 indexed citations
17.
Geenes, Victoria, Jenny Chambers, Rshmi Khurana, et al.. (2015). Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 189. 59–63. 67 indexed citations
18.
Mandair, Dalvinder, Roberta Rossi, Marinos Pericleous, Tara Whyand, & Martyn Caplin. (2014). The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology. 8(4). 369–382. 40 indexed citations
19.
Seijó, Susana, Aurélie Plessier, Jildou Hoekstra, et al.. (2013). Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 57(5). 1962–1968. 173 indexed citations
20.
Mandair, Dalvinder & Martyn Caplin. (2012). Colonic and rectal NET's. Best Practice & Research Clinical Gastroenterology. 26(6). 775–789. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marinos Pericleous Breakdown of academic impact, for papers by Alexandros Papalampros Breakdown of academic impact, for papers by Richard Ho Breakdown of academic impact, for papers by Joseph K. Lim Breakdown of academic impact, for papers by Gerald Denk Breakdown of academic impact, for papers by Anne Davit–Spraul Breakdown of academic impact, for papers by G. Mantion Breakdown of academic impact, for papers by Francesca Carubbi Breakdown of academic impact, for papers by S. Krähenbühl
Rankless by CCL
2026